Latest Headlines

  1. Novotech Recognized For Excellence In Business Expansion, Innovation, And Marketing At The 2024 Clinical Trials Arena Excellence Awards 11/12/2024

    Novotech, the global full-service clinical Contract Research Organization (CRO), has received multiple awards in the 2024 Clinical Trials Arena Excellence Awards, recognizing the achievements of our people in Business Expansion, Innovation, and Marketing. These awards highlight our commitment to advancing the clinical trial landscape and delivering specialized solutions across the biotech sector.

  2. Show Chwan Health Care System Joins Novotech To Accelerate The Quality Of International Clinical Trials Of New Drugs 11/12/2024

    Show Chwan Health Care System announced that it has signed a Memorandum of Understanding (MOU) with Novotech, a clinical research organization (CRO) in the Asia-Pacific region. It will use Novotech’s experience in planning clinical trials to target Changhua and the introduction of new clinical trial cases in Tainan, which will help doctors and patients get in touch with the latest treatment technologies and shorten the development period of new drugs.

  3. Theragent And CellVax Therapeutics Announce First Patient Dosed In Phase 2 Trial of FK-PC101, A Novel Personalized Cancer Immunotherapy 11/11/2024

    Theragent Inc., a comprehensive CDMO focused on advancing next-generation cell-based therapies, has announced a significant milestone for both Theragent and its sponsor client, CellVax Therapeutics Inc. This past week, Theragent produced the first batch of autologous cancer vaccine to dose the first patient in CellVax Therapeutics' randomized Phase 2 clinical trial for FK-PC101.

  4. Avance Clinical CEO And Asia Director Sign MOUs With Key Clinical Trial Sites In Korea Around 2024 KoNECT 10/30/2024

    Avance Clinical, a leading full-service global Contract Research Organization (CRO) known for delivering high-quality, agile clinical research services, is proud to announce the signing of three significant Memorandums of Understanding (MOUs) with key Korean clinical sites during KoNECT 2024 conference.

  5. Accelerate Antibody Capture With Sartobind® Rapid A Lab For Fast, Flexible, And Future-Proof Affinity Chromatography 10/28/2024

    The life science group Sartorius is launching Sartobind® Rapid A Lab, the latest innovation in our portfolio of laboratory separation technologies. Featuring the fastest Protein A matrix on the market, this groundbreaking affinity chromatography unit is set to deliver unparalleled productivity and transform antibody purification processes.

  6. Celebrating The Successful Launch Of Cryoport Systems' IntegriCell™ Cryopreservation Facility In Houston 10/22/2024

    On October 22, Cryoport Systems marked an exciting milestone with the official launch of our IntegriCell™ Cryopreservation facility at the Cryoport Supply Chain Campus in Houston.

  7. New York Blood Center Enterprises To Partner In Governor Hochul's Nation-Leading Cell And Gene Therapy Innovation Hub: New York Biogenesis Park 10/22/2024

    Governor Kathy Hochul yesterday announced plans for New York BioGenesis Park (NYBGP), a groundbreaking $430 million Cell and Gene Therapy (CGT) Innovation Hub that will position New York as a global leader in CGT research, development, and innovation.

  8. Join Avance Clinical At Biotech Showcase 2025 10/17/2024

    Avance Clinical, with over 30 years of experience as a leading full-service Contract Research Organization (CRO), is looking forward to once again meet with biotechs at Biotech Showcase 2025.

    With over 30 years of experience as a full-service Contract Research Organization (CRO) and known for our leading EARLY PHASE specialist clinical research in Australia, we are committed to delivering high-quality, compliant clinical trials.

  9. Join Avance Clinical At The CNS Summit 2024 10/17/2024

    Avance Clinical is thrilled to announce our participation in the CNS Summit 2024, taking place from November 10 – 13, 2024, in Boston, MA. The CNS Summit is a premier event dedicated to advancing clinical development and technology innovation in the Central Nervous System (CNS) therapeutic area. The Summit brings together a curated group of top decision makers from pharma, biotech, CROs, investigator sites, patient advocacy groups, investors and other stakeholders.

  10. 2024 KoNECT-MOHW-MFDS International Conference (KIC) Meet Avance in Seoul 10/17/2024

    Avance Clinical is proud to announce our attendance at the 2024 KoNECT-MOHW-MFDS International Conference (KIC) in Seoul, South Korea, October 29 – 31, 2024. As part of our commitment to expanding our global presence and strengthening our capabilities in the Asia-Pacific region, CEO Yvonne Lungershausen and Asia Regional Director Jessica Han will be attending the conference, meeting with biotech clients and partners to discuss opportunities in early and late-phase clinical trials.